Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UBT251 in Overweight/Obese Patients
NCT07177469Phase 2Completed
- Start
- Mar 2025
- Primary completion
- Oct 2025
- Modality
- Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of UBT251 in obesity. Started Mar 2025; status: completed.
02
Drugs
UBT251
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07177469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07177469.